PERSPECTA

News from every angle

← Back to headlines

Krystal Biotech, Axsome Therapeutics Announce Quarterly Earnings

Krystal Biotech and Axsome Therapeutics have released their latest quarterly financial results. Krystal Biotech reported GAAP EPS and revenue that both beat analyst expectations, while Axsome Therapeutics beat revenue estimates but missed on GAAP EPS.

4 May, 11:03 — 4 May, 11:03
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed23d ago

Krystal Biotech GAAP EPS of $1.83 beats by $0.39, revenue of $116.36M beats by $4.23M

Read full article →

Related Stories

Extreme Training: What Heat Training Does to the Body

just now

Finland's Shelters Face Capacity Shortages, THL Urges Continued Help-Seeking

29m ago

Experts Advocate Lifestyle Changes Over Drugs for Chronic Disease Management

32m ago

Kyle Busch's Cause of Death Revealed as Bacterial Pneumonia

42m ago